Viewing Study NCT03769103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2026-02-19 @ 8:23 PM
Study NCT ID: NCT03769103
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-31
First Post: 2018-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
Sponsor: British Columbia Cancer Agency
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer Non-small Cell Stage IV View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR positive View
None Osimertinib View
None SRS View